DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain

Molecular Therapy

Volumn 15, Issue 9, 2007, Pages 1593-1599

  Appaiahgari, Mohan Babu ^a   Vrati, Sudhanshu ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYNUCLEOTIDE; POLYGUANYLIC ACID; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDEMIC ENCEPHALITIS; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; RNA SEQUENCE; VIRUS INFECTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; BRAIN; CELL LINE; DNA, CATALYTIC; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; MICE; POLY G; RNA, VIRAL; VIRUS REPLICATION;

ANIMALIA; ARTHROPODA; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; MUS; SUGARCANE RAMU STUNT DISEASE PHYTOPLASMA;

EID: 34548075186     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300231     Document Type: Article

References (42)

1. World Health Organization (1998). Japanese encephalitis vaccines. Wkly Epidemiol Rec 73: 337-344.
2. Vrati, S, Giri, RK, Razdan, A and Malik, P (1999). Complete nucleotide sequence of an Indian strain of Japanese encephalitis virus: Sequence comparison with other strains and phylogenetic analysis. Am J Trop Med Hyg 61: 677-680.
3. Ta, M and Vrati, S (2000). Mov34 protein from mouse brain interacts with the 3′ noncoding region of Japanese encephalitis virus. J Virol 74: 5108-5115.
4. Chambers, TJ, Hahn, CS, Galler, R and Rice, CM (1990). Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44: 649-688.
5. Brinton, MA, Fernandez, AV and Dispoto, JH (1986). The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology 153: 113-121.
6. Proutski, V, Gould, EA and Holmes, EC (1997). Secondary structure of the 3′ untranslated region of flaviviruses: Similarities and differences. Nucleic Acids Res 25: 1194-1202.
7. Takegami, T, Washizu, M and Yasui, K (1986). Nucleotice sequence at the 3′ end of Japanese encephalitis virus genomic RNA. Virology 152: 483-486.
8. Shi, PY, Brinton, MA, Veal, JM, Zhong, YY and Wilson, WD (1996). Evidence for the existence of a pseudoknot structure at the 3′ terminus of the flavivirus genomic RNA. Biochemistry 35: 4222-4230.
9. Gritsun, TS and Gould, EA (2006). Direct repeats in the 3′ untranslated regions of mosquito-borne flaviviruses: Possible implications for virus transmission. J Gen Virol 87: 3297-3305.
10. Hahn, CS, Hahn, YS, Rice, CM, Lee, E, Dalgarno, L, Strauss, EG et al. (1987). Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol 198: 33-41.
11. Men, R, Bray, M, Clark, D, Chanock, RM and Lai, CJ (1996). Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: Analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J Virol 70: 3930-3937.
12. Mandl, CW, Holzmann, H, Meixner, T, Rauscher, S, Stadler, PF, Allison, SL et al. (1998). Spontaneous and engineered deletions in the 3′ noncoding region of tick-borne encephalitis virus: Construction of highly attenuated mutants of a flavivirus. J Virol 72: 2132-2140.
13. Santoro, SW and Joyce, GF (1997). A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 94: 4262-4266.
14. Achenbach, JC, Chiuman, W, Cruz, RP and Li, Y (2004). DNAzymes: From creation in vitro to application in vivo. Curr Pharm Biotechnol 5: 321-336.
15. Stearns, ME, Kim, G, Garcia, F and Wang, M (2004). Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells. Mol Concer Res 2: 403-416.
16. Isaka, Y, Nakamura, H, Mizui, M, Takabatake, Y, Horio, M, Kawachi, H et al. (2004). DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 66 586-590.
17. Mitchell, A, Dass, CR, Sun, LQ and Khachigian, LM (2004). Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res 32: 3065-3069.
18. Santiago, FS, Lowe, HC, Kavurma, MM, Chesterman, CN, Baker, A, Atkins, DG et al. (1999). New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 5: 1264-1269.
19. Oketani, M, Asahina, Y, Wu, CH and Wu, GY (1999). Inhibition of hepatitis C virus-directed gene expression by a DNA ribonuclease. J Hepatol 31: 628-634.
20. Goila, R and Banerjea, AC (2001). Inhibition of hepatitis B virus X gene expression by novel DNA enzymes. Biochem J 353: 701-708.
21. Toyoda, T, Imamura, Y, Takaku, H, Kashiwagi, T, Hara, K, Iwahashi, J et al. (2000). Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme. FEBS Lett 481: 113-116.
22. Takahashi, H, Hamazaki, H, Habu, Y, Hayashi, M, Abe, T, Miyano-Kurosaki, N et al. (2004). A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells. FEBS Lett 560: 69-74.
23. Sumiyoshi, H, Mori, C, Fuke, I, Morita, K, Kuhara, S, Kondou, J et al. (1987). Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497-510.
24. Unwalla, H and Banerjea, AC (2001). Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA. Biochem J 357: 147-155.
25. Sioud, M and Leirdal, M (2000). Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application. J Mol Biol 296: 937-947.
26. Chen, CJ, Liao, SL, Kuo, MD and Wang, YM (2000). Astrocytic alteration induced by Japanese encephalitis virus infection. Neuroreport 11: 1933-1937.
27. Suri, NK and Banerjee, K (1995). Growth and cytopathic effect of Japanese encephalitis virus in astrocyte-enriched cell cultures from neonatal mouse brains. Acta Virol 39: 143-148.
28. Iwasaki, Y, Zhao, JX, Yamamoto, T and Konno, H (1986). Immunohistochemical demonstration of viral antigens in Japanese encephalitis. Acta Neuropathol (Berl) 70: 79-81.
29. Wang, JJ, Liao, CL, Chiou, YW, Chiou, CT, Huang, YL and Chen, LK (1997). Ultrastructure and localization of E proteins in cultured neuron cells infected with Japanese encephalitis virus. Virology 238: 30-39.
30. Husemann, J, Loike, JD, Anankov, R, Febbraio, M and Silverstein, SC (2002). Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system. Glia 40: 195-205.
31. Li, Y, Liu, L, Liu, D, Woodward, S, Barger, SW, Mrak, RE et al. (2004). Microglial activation by uptake of fDNA via a scavenger receptor. J Neuroimmunol 147: 50-55.
32. Christie, RH, Freeman, M and Hyman, BT (1996). Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol 148: 399-403.
33. Bell, MD, Lopez-Gonzalez, R, Lawson, L, Hughes, D, Fraser, I, Gordon, S et al. (1994). Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol 23: 605-613.
34. Sommer, W, Cui, X, Erdmann, B, Wiklund, L, Bricca, G, Heilig, M et al. (1998). The spread and uptake pattern of intracerebrally administered oligonucleotices in nerve and glial cell populations of the rat brain. Antisense Nucleic Acid Drug Dev 8: 75-85.
35. Ogawa, S, Brown, HE, Okano, HJ and Pfaff, DW (1995). Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain. Regul Pept 59: 143-149.
36. Prasad, V, Hashim, S, Mukhopadhyay, A, Basu, SK and Roy, RP (1999). Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: Enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide. Antimicrob Agents Chemother 43: 2689-2696.
37. Acosta, R, Montanez, C, Gomez, P and Cisneros, B (2002). Delivery of antisense oligonucleotides to PC12 cells. Neurosci Res 43: 81-86.
38. Takakura, Y, Oka, Y and Hashida, M (1998). Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells. Antisense Nucleic Acid Drug Dev 8: 67-73.
39. Zhao, Q, Matson, S, Herrera, CJ, Fisher, E, Yu, H and Krieg, AM (1993). Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and m ethyl phosphonate oligonucleotides. Antisense Res Dev 3: 53-66.
40. Beck, GF, Irwin, WJ, Nicklin, PL and Akhtar, S (1996). Interactions of phosphodiester and phosphorothioate oligonucleotices with intestinal epithelial Caco-2 cells. Pharm Res 13: 1028-1037.
41. Ghoshal, A, Das, S, Ghosh, S, Mishra, MK, Sharma, V, Koli, P et al. (2007). Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55: 483-496.
42. Vrati, S, Agarwal, V, Malik, P, Wani, SA and Saini, M (1999). Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 80 1665-1671.